VAG Forte™ - References

I Product Info I Ingredients
I Recommended Use
I Clinical Trials
I Research Brief
I References 


60 tablets/30 days


Order this item

Low USA domestic & international shipping


  • helps to maintain the women's hormonal balance,
  • helps to normalize the menstrual cycle,
  • provides anti-inflammatory and anti-bacterial action,
  • overall toning and strengthening action.


  • inflammatory processes in the female reproductive organs,
  • menstrual cycle disturbance,
  • premenstrual syndrome (PMS).

Ingredients (per 1 tablet):

  • Black cohosh (Cimicifuga foetida) root extract (12:1) 8% triterpene glycosides (as 27-deoxyactein)] (equivalent to 150 mg of crude herb) – 12.5 mg,
  • Proprietary Blend – 300 mg:
  • Chickweed (Stellaria media L.)(aerial parts),
  • Marshmallow root (Althaea officinalis L.),
  • Mullein leaf (Verbascum thapsus),
  • Slippery elm (Ulmus rubra) bark,
  • Yellow dock (Rumex crispus L.) root.


  • 60 tablets, 1 tablets twice a day. 

VAG Forte™ - References:

1. Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 12–3.
2. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Use of botanicals for management of menopausal symptoms. Obstet Gynecol 2001;97:suppl 1-11.
3. Lieberman S, A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health. 1998 Jun;7(5):525-9.
4. T.R. Rebbeck, A.B. Troxel, S. Norman, G.R. Bunin, A. DeMichele, M. Baumgarten, M. Berlin, R. Schinnar, B.L. Strom. "A retrospective case-control study of the use of hormone-related supplements and association with breast cancer". International Journal of Cancer, 1 April 2007, Volume 120, Issue 7, Pages 1523-1528.
5. Warnecke, G: Influencing of menopausal complaints with a phytodrug: successful therapy with Cimicifuga monoextract (in German). Medizinische Welt 36: 871-874, 1985.
6. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Seidlová-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. Maturitas. 2003 Mar 14;44 Suppl 1:S39-50